Literature DB >> 17444847

Asian Pacific Association for the Study of the Liver consensus statements on the diagnosis, management and treatment of hepatitis C virus infection.

G W McCaughan, M Omata, D Amarapurkar, S Bowden, W C Chow, A Chutaputti, G Dore, E Gane, R Guan, S S Hamid, W Hardikar, C K Hui, W Jafri, J-D Jia, M-Y Lai, L Wei, N Leung, T Piratvisuth, S Sarin, J Sollano, R Tateishi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17444847     DOI： 10.1111/j.1440-1746.2007.04883.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN： 0815-9319            Impact factor:   4.029


× No keyword cloud information.
  49 in total

1.  Rate and factors affecting treatment uptake of patients with chronic hepatitis C in a tertiary referral hospital.

Authors:  Kenneth Kar-Lung Yan; Grace Lai-Hung Wong; Vincent Wai-Sun Wong; Henry Lik-Yuen Chan
Journal:  Dig Dis Sci       Date:  2010-10-07       Impact factor: 3.199

2.  Development of a second version of the Cobas AmpliPrep/Cobas TaqMan hepatitis C virus quantitative test with improved genotype inclusivity.

Authors:  Johannes Vermehren; Giuseppe Colucci; Peter Gohl; Nabila Hamdi; Ahmed Ihab Abdelaziz; Ursula Karey; Diana Thamke; Heike Zitzer; Stefan Zeuzem; Christoph Sarrazin
Journal:  J Clin Microbiol       Date:  2011-07-13       Impact factor: 5.948

Review 3.  Hepatitis C virus genotype 6: virology, epidemiology, genetic variation and clinical implication.

Authors:  Vo Duy Thong; Srunthron Akkarathamrongsin; Kittiyod Poovorawan; Pisit Tangkijvanich; Yong Poovorawan
Journal:  World J Gastroenterol       Date:  2014-03-21       Impact factor: 5.742

Review 4.  International standards and reference materials for quantitative molecular infectious disease testing.

Authors:  Roberta M Madej; Jack Davis; Marcia J Holden; Stan Kwang; Emmanuel Labourier; George J Schneider
Journal:  J Mol Diagn       Date:  2010-01-14       Impact factor: 5.568

5.  On-treatment monitoring of HBV DNA levels: predicting response and resistance to oral antiviral therapy at week 24 versus week 48.

Authors:  Ting-Tsung Chang
Journal:  Hepatol Int       Date:  2009-07-30       Impact factor: 6.047

Review 6.  Viral hepatitis in elderly haemodialysis patients: current prevention and management strategies.

Authors:  Matthias Girndt
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

Review 7.  Controversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinoma.

Authors:  Pei-Pei Song; Ju-Feng Xia; Yoshinori Inagaki; Kiyoshi Hasegawa; Yoshihiro Sakamoto; Norihiro Kokudo; Wei Tang
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

Review 8.  Antiviral therapy of chronic hepatitis C in patients with advanced liver disease and after liver transplantation.

Authors:  Jan Peveling-Oberhag; Stefan Zeuzem; Wolf Peter Hofmann
Journal:  Med Microbiol Immunol       Date:  2009-11-10       Impact factor: 3.402

9.  Serum microRNA-122 level correlates with virologic responses to pegylated interferon therapy in chronic hepatitis C.

Authors:  Tung-Hung Su; Chen-Hua Liu; Chun-Jen Liu; Chi-Ling Chen; Te-Tien Ting; Tai-Chung Tseng; Pei-Jer Chen; Jia-Horng Kao; Ding-Shinn Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-23       Impact factor: 11.205

10.  Nutritional status in relation to lifestyle in patients with compensated viral cirrhosis.

Authors:  Fumikazu Hayashi; Chika Momoki; Miho Yuikawa; Yuko Simotani; Etsushi Kawamura; Atsushi Hagihara; Hideki Fujii; Sawako Kobayashi; Shuji Iwai; Hiroyasu Morikawa; Masaru Enomoto; Akihiro Tamori; Norifumi Kawada; Satoko Ohfuji; Wakaba Fukusima; Daiki Habu
Journal:  World J Gastroenterol       Date:  2012-10-28       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.